Takeda Pharmaceutical (TAK) News Today $12.94 -0.11 (-0.80%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Legacy Wealth Asset Management LLC Sells 20,779 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Legacy Wealth Asset Management LLC lessened its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 12.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 140,837 sharJanuary 17 at 5:51 AM | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Clean Yield GroupClean Yield Group trimmed its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 360,091 shares of the company's stock after sellinJanuary 13, 2025 | marketbeat.comBoston office market starts 2025 with record-high vacancy rateJanuary 9, 2025 | bizjournals.comTakeda Pharmaceutical (NYSE:TAK) Sees Unusually-High Trading Volume - Here's WhyTakeda Pharmaceutical (NYSE:TAK) Sees Unusually-High Trading Volume - Here's What HappenedJanuary 8, 2025 | marketbeat.comONL Therapeutics Appoints Penny Fleck as Chief Development OfficerJanuary 7, 2025 | finance.yahoo.comHUTCHMED to divest 45% equity interest in SHPL for $608mJanuary 2, 2025 | msn.comTakeda Reports Approval Of HYQVIA Injection Set In Japan - Quick FactsDecember 27, 2024 | markets.businessinsider.comTakeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or HypogammaglobulinemiaDecember 27, 2024 | businesswire.comJane Street Group LLC Has $1.73 Million Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Jane Street Group LLC trimmed its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 91.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 121,830 shares of the company's stock after selling 1,December 26, 2024 | marketbeat.com42,244 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Purchased by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio bought a new stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 42,244 shares of the company's stock, valued at approximately $601,000. A numberDecember 21, 2024 | marketbeat.comHighTower Advisors LLC Purchases 81,653 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)HighTower Advisors LLC boosted its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 199.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 122,587 shares of the company's stock after purchasinDecember 15, 2024 | marketbeat.comStifel Financial Corp Grows Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Stifel Financial Corp grew its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 103.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 440,666 shares of the company's stock afDecember 14, 2024 | marketbeat.comKeros Stock Hits Rock Bottom After Pulmonary Hypertension Trial Halt, But Retail Bets On A ReboundDecember 12, 2024 | msn.comKeros Therapeutics: How To Respond To Today's Major Safety Setback And SelloffDecember 12, 2024 | seekingalpha.comJanus Henderson Group PLC Reduces Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Janus Henderson Group PLC trimmed its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 17.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 256,447 shares of the company's stock after sellDecember 12, 2024 | marketbeat.comJ.P. Morgan Remains a Sell on GlaxoSmithKline (GSK)December 11, 2024 | markets.businessinsider.com67,286 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Purchased by XTX Topco LtdXTX Topco Ltd bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 67,286 shares of the company's stock, valued at approDecember 11, 2024 | marketbeat.comTakeda Pharmaceutical (TSE:4502) Advances with New Product Update and Strategic Alliances for GrowthDecember 10, 2024 | finance.yahoo.comFmr LLC Buys 286,052 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Fmr LLC boosted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 10.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,908,918 shares of the company's stock after acquiringDecember 8, 2024 | marketbeat.comTakeda Pharmaceutical: Dividend Yield Is High But Hides Pitfalls Especially For US InvestorsDecember 7, 2024 | seekingalpha.com107,808 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Purchased by Verition Fund Management LLCVerition Fund Management LLC bought a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 107,808 shares oDecember 7, 2024 | marketbeat.comTeva Pharma To Divest Teva-Takeda Business Venture In Japan To JKIDecember 5, 2024 | markets.businessinsider.comKeros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: AnalystDecember 3, 2024 | benzinga.comKeros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: AnalystDecember 3, 2024 | benzinga.comTakeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros TherapeuticsDecember 3, 2024 | businesswire.comCerity Partners LLC Buys 61,271 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Cerity Partners LLC boosted its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 93.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 127,071 shares of the company's stock afDecember 3, 2024 | marketbeat.comTakeda Shows Strong Growth and Raises GuidanceNovember 29, 2024 | markets.businessinsider.comAlloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy PlatformNovember 20, 2024 | businesswire.comAnalysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)November 19, 2024 | markets.businessinsider.comHalozyme says €2 billion takeover of Evotech would create leader in drug discoveryNovember 19, 2024 | msn.comOppenheimer Asset Management Inc. Sells 56,430 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Oppenheimer Asset Management Inc. lowered its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 22.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 197,199 shares of theNovember 17, 2024 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Short Interest Down 17.4% in OctoberTakeda Pharmaceutical Company Limited (NYSE:TAK - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 6,030,000 shares, a decline of 17.4% from the October 15th total of 7,300,000 shares. Based on an average daily trading volume, of 1,650,000 shares, the short-interest ratio is currently 3.7 days.November 15, 2024 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comBiocom California appoints two Bay Area executives to board of governorsNovember 13, 2024 | bizjournals.comXY Capital Ltd Sells 179,563 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)XY Capital Ltd cut its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 52.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 164,486 shares of the company's stock after selling 179,563 shares during the qNovember 9, 2024 | marketbeat.comSummit Global Investments Grows Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Summit Global Investments grew its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 86.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 415,558 shares of the company's stock after acquiring an additional 192,143 sharesNovember 8, 2024 | marketbeat.comAlphaCentric Advisors LLC Invests $1.14 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)AlphaCentric Advisors LLC purchased a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund purchased 80,000 shares of the company's stock, valued at approximately $1,138,November 5, 2024 | marketbeat.comRaymond James & Associates Has $2.75 Million Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Raymond James & Associates trimmed its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 24.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 193,566 shares of the compaNovember 5, 2024 | marketbeat.comTakeda Pharmaceutical Reports Strong Revenue Growth in 2024November 2, 2024 | markets.businessinsider.comTakeda Pharmaceutical Announces Robust Earnings GrowthNovember 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Takeda Pharmaceutical Company (TAK) and Voyager Therapeutics (VYGR)November 1, 2024 | markets.businessinsider.comFormer Takeda employee sentenced to nearly 4 years for fraudNovember 1, 2024 | bizjournals.comBrookline woman gets jail time for embezzling $2.5 million from TakedaNovember 1, 2024 | msn.comFormer employee sentenced to prison for embezzling over $2.5M from Massachusetts pharmaceutical companyNovember 1, 2024 | msn.comTakeda Pharmaceutical Company Limited 2025 Q2 - Results - Earnings Call PresentationOctober 31, 2024 | seekingalpha.comTakeda H1 Profit Rises; Upgrades 2024 Management GuidanceOctober 31, 2024 | markets.businessinsider.comTakeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance -- UpdateOctober 31, 2024 | marketwatch.comTakeda Pharmaceutical (NYSE:TAK) Releases FY 2024 Earnings GuidanceTakeda Pharmaceutical (NYSE:TAK) updated its FY 2024 earnings guidance. The company provided EPS guidance of 3.060-3.060 for the period.October 31, 2024 | marketbeat.comJapan's Takeda returns to Q2 profit as drugmaker recovers from impairmentsOctober 31, 2024 | reuters.comTakeda Announces Strong First Half FY2024 Results and Raises Full Year OutlookOctober 31, 2024 | businesswire.com Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address TAK Media Mentions By Week TAK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼0.740.44▲Average Medical News Sentiment TAK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼14▲TAK Articles Average Week Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News Today GSK News Today ARGX News Today BNTX News Today TEVA News Today BGNE News Today SMMT News Today GMAB News Today VTRS News Today ITCI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TAK) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
